Your search returned 12 results.

Results
	1.	[Prevention ... it should be a goal for the community]. [electronic resource] by Toft-Nielsen, M Producer: 19730821 In: Sygeplejersken vol. 72 Availability: No items available. Save to lists Add to cart (remove)
	2.	Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia. [electronic resource] by Toft-Nielsen, M Madsbad, S Holst, J J Producer: 19990114 In: Diabetologia vol. 41 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients. [electronic resource] by Toft-Nielsen, M B Madsbad, S Holst, J J Producer: 19990824 In: Diabetes care vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes. [electronic resource] by Toft-Nielsen, M B Madsbad, S Holst, J J Producer: 20010906 In: The Journal of clinical endocrinology and metabolism vol. 86 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	On the treatment of diabetes mellitus with glucagon-like peptide-1. [electronic resource] by Holst, J J Deacon, C Toft-Nielsen, M B Bjerre-Knudsen, L Producer: 19990216 In: Annals of the New York Academy of Sciences vol. 865 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	No effect of beta-adrenergic blockade on hypoglycaemic effect of glucagon-like peptide-1 (GLP-1) in normal subjects. [electronic resource] by Toft-Nielsen, M Hvidberg, A Hilsted, J Dige-Petersen, H Holst, J J Producer: 19961203 In: Diabetic medicine : a journal of the British Diabetic Association vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Additive glucose-lowering effects of glucagon-like peptide-1 and metformin in type 2 diabetes. [electronic resource] by Zander, M Taskiran, M Toft-Nielsen, M B Madsbad, S Holst, J J Producer: 20010802 In: Diabetes care vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	On the effects of glucagon-like peptide-1 on blood glucose regulation in normal and diabetic subjects. [electronic resource] by Holst, J J Toft-Nielsen, M B Orskov, C Nauck, M Willms, B Producer: 19970210 In: Annals of the New York Academy of Sciences vol. 805 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Evaluation of beta-cell secretory capacity using glucagon-like peptide 1. [electronic resource] by Vilsbøll, T Toft-Nielsen, M B Krarup, T Madsbad, S Dinesen, B Holst, J J Producer: 20000918 In: Diabetes care vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects. [electronic resource] by Deacon, C F Nauck, M A Toft-Nielsen, M Pridal, L Willms, B Holst, J J Producer: 19951004 In: Diabetes vol. 44 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Nutrient re-routing and altered gut-islet cell crosstalk may explain early relief of severe postprandial hypoglycaemia after reversal of Roux-en-Y gastric bypass. [electronic resource] by Svane, M S Toft-Nielsen, M B Kristiansen, V B Hartmann, B Holst, J J Madsbad, S Bojsen-Møller, K N Producer: 20180727 In: Diabetic medicine : a journal of the British Diabetic Association vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. [electronic resource] by Toft-Nielsen, M B Damholt, M B Madsbad, S Hilsted, L M Hughes, T E Michelsen, B K Holst, J J Producer: 20010906 In: The Journal of clinical endocrinology and metabolism vol. 86 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)